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Cue Exposure Revisited
Classical conditioning has been the predominant discourse in cue exposure research in the 
addictions. It would be wrong, however, to restrict the definition of cue exposure exclusively to a 
conditioning theory based mechanism since there are many other possible explanations for the 
effects of exposure to cues. This paper proposes that cue exposure is a valuable investigative 
technique that can be studied from a variety of different perspectives that include social learning 
theory and other cognitive models. A potential of cue exposure is that it provides a means of 
developing an understanding of addictive behaviour that is firmly rooted in widely studied general 
theories of behaviour. Furthermore, it provides a methodology to test hypotheses and to study 
mechanisms of cue reactivity and the effects of cues on problem drinking. In the clinical area in 
particular, cue exposure affords a more precise method to study the phenomenon of relapse and 
ultimately, the effects of cue exposure on clinical outcome.
Introduction
The desire to drink when faced with alcohol cues has traditionally been acknowledged as a classical 
conditioning process. While interpretations of the cue reactivity paradigm were initially derived 
from the framework of classical conditioning, it has been argued that it is too limiting to restrict the 
definition of cue exposure to a conditioning theory-based mechanism (Drummond et al., 1995). 
There are many other possible explanations for the effects of exposure to cues, with social learning 
theory as a leading alternative candidate. Exposure to alcohol cues results in physiological, cognitive 
and behavioural reactions which are inextricably inter-linked and mutually interdependent. Just as 
with neurosis, the term “desynchrony” has been applied to acknowledge the difficulties in mapping 
relationships between the three (Rachman & Hodgson, 1974; Rachman, 1978). The range of cues 
that may be relevant is potentially infinite. Exteroceptive cues include basic perceptions such as 
sight, smell and taste of alcohol and the more complex involve alcohol advertising or temporal cues 
such as the time of day when alcohol is normally consumed. Interoceptive cues can range from the 
sensation of alcohol entering the stomach to the effects of alcohol on the central nervous system. 
One drink may act as a cue for further drinking, the so-called ‘priming dose effect’, which has been 
demonstrated in both alcohol-dependent and non-dependent subjects (Drummond et al., 1995). 
Interoceptive cues can also include moods (such as euphoria or anger), cognitions (such as beliefs 
about the effects of alcohol) and those related to the withdrawal phase that can occur many hours 
after the initial drinking episode.
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The aim of the present paper is to demonstrate how cue exposure, as a procedure, can be used to 
extend our knowledge and understanding of alcohol problems. It is proposed that cue exposure is a 
valuable investigative technique that can be studied from a variety of different theoretical 
standpoints. In cue exposure we have a means of developing an understanding of addictive 
behaviour that is firmly rooted in widely studied theories of general behaviour, theories that have 
been successfully applied to other human disorders (Drummond et a l, 1995). As we increase our 
understanding and ability to measure cue reactivity, we increase the likelihood of developing clinical 
techniques that are located within a sound scientific framework. The challenge is to make links 
between advances in all areas and move away from the somewhat focused approach that has existed 
until recently.
The paper will attempt to do this by focusing on examples from four areas. Firstly, there will be a 
discussion of the way in which cue exposure studies have extended our understanding of cue 
reactivity and have incorporated it within a social learning framework. Secondly, the social learning 
construct of self-efficacy will be discussed with emphasis on how it can modify the effects of cue 
exposure and experience of craving. Craving in the absence of ongoing drinking is of particular 
relevance for the study of cue-reactivity and relapse. The third area to be explored will be disulfiram 
treatment. It has been hypothesised that disulfiram may act as a form of cue exposure and response 
prevention which could result in the extinction of conditioned craving. Some of the questions that 
this hypothesis raises will be examined. Finally, a cognitive processing model of cue reactivity will 
be described. This model rejects craving as a central process in alcohol problems and asserts that 
physiological reactions to alcohol related cues may be reflecting the cognitive and behavioural 
demands of the situation.
Cue Exposure Studies
Some authors have questioned the value of cue reactivity in the relapse process (Chaney, Roszell & 
Cummings, 1982; Marlatt, 1985). Others have contributed to the numerous studies exploring the 
significance of cue reactivity in relation to alcohol problems. The first randomised group clinical 
trial of cue exposure was conducted by Rankin, Hodgson & Stockwell (1983). Results showed a 
decrease in desire for alcohol following in-vivo cue exposure compared to imaginal exposure. 
Unfortunately, the study had a very small sample size (n = 10) which limits the generalisability of 
the results and no follow-up data was reported. Treatment was performed in a controlled inpatient 
setting and was unable to provide information about the long-term effectiveness of cue exposure 
treatment following discharge. Laberg (1990) reported the outcome of a series of studies on cue 
reactivity carried out at the Hjellestad Clinic in Norway. These studies supported the notion
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previously proposed by Stockwell et al (1982), that degree of dependence is an important 
determinant of a problem drinker’s reaction to drinking cues. They also replicated previous findings 
that expectation of receiving alcohol exerted a greater influence on craving than the 
pharmacological effects of alcohol, regardless of the degree of dependence. Overall, it was shown 
that alcohol expectations could elicit significant alcohol-specific responses in problem drinkers. 
Under experimental control, an apparently weak verbal cue was sufficient to elicit behavioural, 
subjective and physiological responses in problem drinkers, regardless of internal pharmacological 
effects following the ingestion of alcohol. These findings support both conditioning and social 
learning models of cue reactivity. In a one-year follow-up study (Loberg et a l, 1988), it was found 
that subjects who had participated in drinking experiments were not adversely affected in terms of 
post treatment drinking outcome. Some subjects reported that participation in these experiments 
resulted in an increase in feelings of coping, when they were successful in resisting further drinking. 
The results of the Norwegian studies lend strong support to a range of other studies (Blakey & Baker, 
1979; Hodgson & Rankin, 1976; Rankin et a l, 1983), which suggested that exposure to alcohol 
related stimuli, in combination with response prevention training, led to a reduction in craving.
A study by Monti et al (1993) investigated the combined effectiveness of cue exposure with coping 
skills training compared with a contrast condition involving daily contact with assessment only, in 
addition to standard treatment. Subjects who had received the experimental treatment had a higher 
incidence of abstinence and a higher percentage of abstinent days during the 3 to 6 months post 
treatment than those who had received the standard treatment alone. The fact that some of the 
experimental subjects who drank during the first 3 months were completely abstinent during the next 
three months is consistent with the idea that these patients applied coping skills after lapsing to 
return to abstinence but is inconsistent with an extinction based explanation of the treatment effects. 
In a study by Drummond & Glautier (1994), subjects were assigned to either a cue exposure 
condition or to a relaxation control condition in addition to standard inpatient treatment. The 
authors reported that after a 6 month follow-up period, cue exposure clients did better than controls 
in terms of latency to reinstatement of heavy drinking, dependence and in quantity consumed. In 
this study, regression analyses showed that treatment group and cue reactivity independently 
predicted outcome in terms of latency to reinstatement of heavy drinking and dependence. The 
mechanism of cue exposure, as suggested by the cue exposure hypothesis, may be more complex than 
that proposed by a learning model which relies exclusively on reactivity. They speculate that an 
increase in self-efficacy may have facilitated the use of coping skills in resisting heavier drinking 
once drinking began. This was similar to the conclusion previously reached by Monti et al (1993).
It would appear that extinction of classically conditioned physiological responses is the only 
mechanism by which cue exposure treatments may reduce drinking. Other mechanisms of action are 
a broader operant conditioning model and a social learning model of drinking (Abrams & Niaura, 
1987). These involve several cognitive and information processing factors, including breaking the 
chain of behaviours leading to drinking, disconfirming expectations about the effects of exposure to
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drinking cues, developing coping skills and strengthening efficacy expectations regarding the ability 
to resist drinking when faced with alcohol related cues.
Self-efficacy
There is abundant evidence that self-efficacy is an important factor in relapse (Burling et al., 1989; 
Solomon & Annis, 1990). There is also strong empirical evidence of the power of self-efficacy 
judgements in predicting drinking behaviour (Ritz & Watzl, 1983; Annis & Davis, 1988). . 
Drummond et al. (1995) have suggested that Bandura’s theory of self-efficacy may provide an 
important additional dimension to our understanding of the effects of cue exposure on relapse. They 
stated that: “In the face of difficulties, people who entertain serious doubts about their capacities 
slacken their efforts or give up altogether, whereas those who have a strong sense of efficacy exert 
greater effort to master the challenge” (Bandura, 1981, p. 201). High levels of efficacy are posited to 
offer protection from relapse whereas low levels make it less likely that the problem drinker will 
engage in necessary coping responses and avoid relapse. A basic tenet of this view is that craving 
and self-efficacy are reciprocally related. High craving, because it presents a challenge to the 
problem drinkers coping skills, is hypothesised to reduce self-efficacy beliefs. Low self-efficacy 
should exacerbate alcohol craving, primarily by augmenting the incentive properties of anticipated 
alcohol effects. Bandura (1981), also predicted that increased aversive arousal, particularly one over 
which an individual has no control, is likely to result in decreased self-efficacy. Arousal induced by 
conditioned responses to alcohol related cues may have a direct effect on self-efficacy as well as 
outcome expectancy. In a study by Cooney et al. (1987) cognitive changes following cue exposure 
were examined in abstinent problem drinkers and non-problem drinkers. Their results showed that 
problem drinkers responded to alcohol cues with reports of increased physical symptoms, decreased 
confidence about coping with future temptation, and increased guilt. These results are in accord with 
the views of several authors (Marlatt & Gordon, 1985; Wills & Shiffinan, 1985), who claim that 
motivation for alcohol consumption involves a multiplicity of biopsychosocial determinants. In 
addition to conditioned cue effects, they argue that relapse is influenced by physiological, affective 
and cognitive variables as they interact in a ‘high risk situation’. Marlatt (1990) has proposed that 
cognitive factors will influence the probability of relapse; if an effective coping response is not 
available to the individual in the high risk situation, self-efficacy (perceived ability to cope with the 
temptation) will reduce. Low self-efficacy is thought to increase the likelihood of craving (Bandura, 
1981).
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Craving
Some researchers (Ludwig & Stark, 1974) have argued that craving is a classical conditioned process 
which suggests that it is an appetitive urge, similar to hunger, that varies in intensity and is 
characterised by withdrawal-like symptoms. A logical implication of all the conditioning models is 
that procedures based on extinction should decrease the probability of relapse. A potentially effective 
treatment method would be based on exposure with response prevention. The model for this 
treatment approach derives from extensive research on obsessive-compulsive and phobic disorders 
(Foa & Kozak, 1986; Rachman & Hodgson, 1980). Just as a phobic individual will not experience 
fear when certain cues can be avoided, but will experience a high degree of fear when escape is 
prevented; an addicted individual may experience minimal craving as long as every urge to drink can 
be followed by alcohol use. According to this view, addicted individuals are likely to experience a 
high degree of craving when remaining abstinent in the presence of drinking cues. Caution has been 
advised, however, against making too great a leap of faith in assuming their equivalence to addictive 
behaviours (Drummond et al., 1995).
The concept of ‘craving’ has been important in the development of cue exposure research. It has 
been argued that the subjective experience of conditioned craving in response to drug cues is the 
important determinant of relapse (Ludwig, Wikler & Stark, 1974). More recently, it has been 
described as an ‘ambiguous concept’ which serves to impede progress in the cue exposure field 
(Drummond, Cooper & Glautier, 1990 p. 728). These authors conclude that the subjective 
experience described as ‘craving’ may represent a variety of different internal states between 
individuals and give rise to erroneous interpretations of the effects of cue exposure. Several 
researchers have expressed the view that craving may arise from the labelling of physiological or 
affective states. (Cooney et al., 1993; Drummond et al., 1990), but none of these researchers have 
provided an extensively formulated cognition-arousal model of craving.
Disulfiram Treatment
The psychological mechanism underlying the use of disulfiram (Antabuse) is deterrence. One 
problem associated with this model is that “it predicts a relapse after the patient has stopped 
drinking” (Heather, 1993 p. 15). One way that disulfiram treatment might effect longer-term 
changes has been proposed by Brewer (1988). He states that disulfiram acts as a form of naturalistic 
cue exposure and response prevention. Heather (1996) states that according to this extinction 
hypothesis, unreinforced exposure (by means of response prevention) to alcohol related cues will lead 
to the extinction of conditioned craving responses. Thus, when a person encounters high-risk
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situations in fixture, craving will not be experienced or will be experienced to a much lesser degree. 
He also proposes an alternative hypothesis which is that repeated ‘mastery experiences’ of 
confronting high-risk situations (with the aid of disulfiram) will lead to greater self-efficacy in 
coping with those high-risk situations in future. According to Heather (1993), it is not necessary for 
this hypothesis that craving subsides. Indeed, self-efficacy theorists may argue that it is important 
for a person to learn to cope with the same high level of craving without relapse. The two 
mechanisms, however, are not mutually exclusive and it may be that both processes can occur 
simultaneously, i.e. the person learns to cope with craving better and that craving reduces in intensity 
through extinction. Craving in the absence of ongoing drinking is of particular relevance for the 
study of cue reactivity and relapse. For example, will the extinction of conditioned craving responses 
occur when the consummatory response (i.e. drinking) is unavailable. Alternatively, could 
disulfiram create a different expectancy set so that patients would not be tempted by alcohol cues 
while on disulfiram, only to be vulnerable after disulfiram has been discontinued (Rohsenow et a l, 
1995). These are among the testable hypotheses that remain to be explored.
Finally, if disulfiram treatment works by operating as a form of cue exposure then one of the ways it 
may affect outcome is by utilising Hammersley’s (1992) concept of ‘breadth of transfer’. This 
recommends that cue exposure should be undertaken in a wide range of settings in the hope that the 
learned extinction will generalise to as many situations as possible. Studies of cue exposure also 
need to explore cues beyond those directly associated with alcohol use. As with the treatment of 
phobias, this would involve tailoring cues more careftxlly to the individual’s needs. More entrenched 
alcohol problems are more likely to require more intensive treatment interventions. Disulfiram 
treatment is frequently considered to be of benefit for those who have failed to respond to simpler 
treatments, or for whom the consequences of an early relapse would be particularly disastrous 
(Brewer, 1988).
A Cognitive Processing Model of Cue Reactivity
A model proposed by Tiffany (1990) concurs with the view that physiological reactions to alcohol 
related cues are not necessarily classically conditioned responses but may be reflecting the cognitive 
and behavioural demands of the situation (see Figure 1.1). According to this model, if an individual 
is addicted to alcohol, drinking is likely to have become an automatic process and will be stimulus 
bound, cognitively effortless and difficult to impede. Conversely, non-automatic processes are 
believed to be slow, dependent upon intention and restricted by limited cognitive capacity. This 
mode of processing is needed in situations in which automatic processes cannot be invoked to 
produce appropriate responses. For example, one situation requiring considerable non-automatic 
processing is when an individual is attempting to thwart engaging in a behaviour that has become
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automatized (Norman & Shallice, 1985; Schneider, Dumais & Shiffrin, 1984). The model 
hypothesises that non-automatic processes will be activated in parallel with drinking schemata. 
These processes will either act in support of the schema and drinking will occur, or act to block the 
automatized sequence from being completed, as will occur when the individual is attempting to 
maintain abstinence. An example of the latter situation would be an individual, recently embarked 
on disulfiram treatment meeting former drinking friends in a setting where alcohol was freely 
available. It is anticipated that this situation will require considerable non-automatic cognitive 
processing to avoid the completion of the drinking action schema. Tiffany (1995) reports that the 
results of several studies suggest craving may disrupt effortful cognitive processes. Many of these 
studies, however, involve craving in smokers (Brandon, Tiffany & Baker, 1987) or are laboratory 
based studies (Wetter, Brandon & Baker, 1992; Sayette, et al., 1994) and may not be applicable for 
problem drinkers in real life settings. Although many of the specific predictions regarding automatic 
and non-automatic processes in alcohol relapse remain to be investigated, existing data on alcohol 
craving and the relationship of craving to alcohol use are not incompatible with this model.
Conclusion
Cue exposure as a technique for treating alcohol dependency is considerably more complex and less 
radically behavioural than it first appeared. This paper has presented a variety of perspectives on the 
degree to which cognitive processes must be invoked to supplement or supplant traditional 
conditioning theories of cue reactivity phenomena. For example, Laberg (1990) reports that 
individuals addicted to alcohol show conditioned alcohol responses when merely told that they are 
going to be offered alcohol. This supports Hammersley’s view that “it is possible that the critical 
cues to drug use are primarily in the user’s mind rather than in the user’s environment” 
(Hammersley, 1992 p. 299). Thus, it is possible that problem drinkers do not automatically crave 
alcohol upon exposure to some stimuli, but instead their cognitive interpretation of the stimuli may 
or may not elicit conditioned responses to alcohol. Cognitive approaches offer mechanisms and 
measures not envisioned by simple conditioning models of cue reactivity. Although cognitive models 
question whether classical conditioning can provide a complete explanation for cue reactivity 
phenomena, none challenges the value of the cue reactivity paradigm nor its ability to contribute to a 
better understanding of alcohol addiction, including recovery and relapse.
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Figure 1.1 Cognitive model processing of cue reactivity (Tiffany, 1990)
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2. MAJOR RESEARCH PROJECT PROPOSAL
Disulfiram treatm ent, self-efficacy and the cue exposure hypothesis
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GREATER GLASGOW COMMUNITY AND MENTAL HEALTH SERVICES NHS TRUST
SUBMISSION OF RESEARCH PROTOCOLS TO THE RESEARCH ETHICS COMMITTEE
All research protocols for consideration by the Research Ethics Committee of Greater Glasgow 
Community and Mental Health Services NHS Trust must be submitted on the standard application 
form, a copy of which is enclosed. Your attention is drawn to the guidance notes to researchers, and 
it is suggested that you read these prior to completing your application.
The application must be completed even when a separate protocol (for example, prepared by a 
pharmaceutical company) exists.
If you wish advice on completing your application, or any aspect of the study you are proposing to 
undertake please contact Mrs Anne McMahon, Medical Director’s Office, Trust Headquarters, 
Gartnavel Royal Hospital.
Tel: 0141-211-3824.
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APPLICATION FORM FOR ETHICAL APPROVAL
NOTES: This application form must be typed, not hand written.
All questions must be answered: it is not an acceptable answer to put see 'separate 
protocol, ‘not applicable ’ is a satisfactory answer where appropriate.
Where a separate protocol exists, this should be submitted in addition to the 
application form.
1. Name and status of proposer: Catherine Keogh
Chartered Clinical Psychologist
Supervisor: Dr. Kate Davidson
Research Tutor
Consultant Clinical Psychologist 
Dept, of Psychological Medicine 
Academic Centre 
Gartnavel Royal Hospital
2. Address for correspondence: Lansdowne Clinic
3 Whittinghame Gardens 
Great Western Rd. 
Glasgow G12 OAA
3. Employing authority:
Greater Glasgow Community and Mental Health Services NHS Trust
4. In which hospital(s) or other location will the study be undertaken: 
Gartnavel Royal Hospital, Glasgow
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5. Title of project:
Disulfiram, self-efficacy and the cue exposure hypothesis
6. Has the proposed research been approved by any other committee on ethics? (Give details): 
No
7. Has the proposed, or similar, research been carried out in any other centre? (Give details) 
No
8. Please give a summary of the project, including the question to be answered, the procedures to 
be used, the measurements to be made and how the data will be analysed (please see question 
15 for recording details of how consent is to be obtained):
The aim of the project is to seek a behavioural explanation of why disulfiram works by exploring 
how it affects an individuals self-efficacy, which is considered to be a central factor in mediating 
change in human behaviour. Disulfiram treatment enables an individual to confront situations 
which are high-risk for relapse while forcibly preventing drinking from taking place. One possible 
explanation is that associated craving responses are extinguished and the individuals self-efficacy is 
increased. Alternatively, self-efficacy may only increase if the individual can attribute the success of 
coping efforts in the high-risk for drinking situation to him/herself. When disulfiram has been 
taken, the credit for coping may be attributed to the disulfiram itself, rather than to a change in 
personal efficacy.
The following hypotheses will be tested:
1. Compared to those who discontinued disulfiram treatment, those clients who remained on 
disulfiram treatment, would show increases in self-efficacy from intake to post-treatment.
2. Clients who remained on disulfiram treatment and have experienced more high-risk situations 
would have higher self-efficacy scores.
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3. Compared to those clients who discontinued disulfiram treatment, those clients who 
continued disulfiram treatment, would report a reduction in craving.
Subjects will be consecutive attenders at the Antabuse Treatment Clinic, Gartnavel Royal Hospital 
who are within one month of having detoxified. All subjects will be interviewed by the applicant. 
Measures will be taken at the beginning of treatment and repeated at 3 and 6 monthly follow-up.
The following self-report measures will be used:
1. Generalised Self-efficacy Scale (Schwarzer & Jerusalem, 1993); a 10 item questionnaire 
which measures generalised self-efficacy.
2. Severity of Alcohol Dependence Questionnaire (Stockwell et al., 1983); a 20 item 
questionnaire which measures physical dependence on alcohol.
3. Inventory of Drinking Situations (Annis, 1987); a 42 item questionnaire which provides a 
profile of an individual’s high-risk for drinking situations.
4. Revised Inventory of Drinking Situations a modification of Annis’ (1987) paper: 
questionnaire which provides a retrospective report of exposure to high-risk situations.
5. Craving Index (West et al., 1984): a 5 item visual analogue scale which has been adapted for 
alcohol use.
6. General Health Questionnaire: (Stockwell et al., 1983); a 28 item questionnaire that includes
4 sub-scales measuring somatic symptoms, anxiety and insomnia, social dysfunction and severe
depression.
An interview schedule will include demographic information such as age, sex, employment 
and marital status. Subjects will be asked about alcohol consumption during the 6 months prior to 
commencing disulfiram treatment.
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9. Please state whether there are any expected benefits to patient care and, if so, summarise.
It is predicted that the study will clarify:
- Which individuals would benefit from treatment aimed at increasing self-efficacy and 
coping strategies.
- Which patients are more likely to default and require additional support.
- An optimum time to withdraw disulfiram treatment which has benefits for individual 
patients and the alcohol treatment service.
10. Please state the likely duration (a) of the project itself and (b) for individual patients: 
(a) 2 years (b) 3 sessions: 60min, 40min, 40min.
11. Please state who will have access to the data and what steps will be taken to keep data 
confidential:
Dr. Iain Smith and myself and staff from the Psychology Dept, and the Alcohol Problems and 
Treatment Unit. Data will be coded to protect patients and stored securely in a locked cabinet in the 
Psychology Department.
12. Please give details of how consent is to be obtained. A copy of the proposed consent form, 
along with a separate patient information sheet, written in simple, non-technical language, 
must be attached to this proposal form.
Patients who are commencing disulfiram treatment will be invited to take part in the study. A patient 
information sheet and consent form is attached.
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13. Is the power of the study sufficient to answer the question that is being asked? Please indicate 
the calculations used for the required sample size, including any assumptions you may have 
made. (If in doubt, please obtain statistical advice).
Power analysis is not appropriate since this is a preliminary and exploratoiy study and the measures 
are being adapted for use with patients receiving disulfiram treatment.
14. What statistical tests will you apply to your results?
Please give details of proposed methods:
Data will be analysed using repeated measures analysis of variance, correlational analysis 
and t-tests.
15. Scientific background to study (give a brief account of relevant research in this area with 
references):
Supervised disulfiram treatment is included in Heather’s list of behavioural interventions which 
show evidence of effectiveness.
H e a t h e r ,  N. (1993) Disulfiram treatment for alcohol problems: is it effective and, if so, why?, in: 
B r e w e r ,  C. (Ed) Treatment Options in Addiction: Medical Management o f Alcohol and Opiate 
Abuse (London, The Royal College of Psychiatrists).
In a review of the disulfiram literature, Brewer concludes that “the evidence for the effectiveness of 
supervised disulfiram has been accumulating since 1967, with no contrary findings”.
B r e w e r ,  C. (1987) Disulfiram treatment for alcoholism, Journal o f the American Medical 
Association, 926, 257.
An increase in self-efficacy has consistently been found from treatment intake to treatment 
completion.
Subjects who have not relapsed at 3-6 months follow-up show higher levels of self-efficacy compared 
to individuals who have relapsed.
B u r l in g ,  T. A., R e i l l y ,  P. M., M o l t e e n ,  J. O. & Z if f ,  D. C. (1989) Self-efficacy and relapse 
among in-patient drug and alcohol abusers: A predictor of outcome, Journal o f Studies on Alcohol, 
50(4), 354-360.
S o lo m o n ,  K . A . &  A n n is ,  H. (1990). Outcome and efficacy expectancy in the prediction of post­
treatment drinking behaviour, British Journal o f  Addiction, 78, 659-665.
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Burling et al. (1989) also found that individuals who maintained abstinence through 6 months 
exhibited a significantly greater increase in self-efficacy from intake to discharge compared to 
individuals who did not maintain abstinence.
16. Does the research involve additional invasive procedures over and above the normal 
treatment of the patient? If so, are there any hazards associated with the procedure?
No
17. Please state any other potential hazards to participants arising from the research, their 
estimated probability (if possible) and the precautions to be taken to meet them:
None
18. Please describe any procedures which may cause discomfort or distress to participants, the 
degree of discomfort or distress entailed and their estimated probability:
19. Who are the proposed participants in the research (and controls if appropriate), and how are 
they to be selected? Please give details of age, sex, numbers involved and any other relevant 
details:
Consecutive attenders at the Antabuse Treatment Clinic, Gartnavel Royal Hospital.
A minimum of 80 patients is envisaged, between the ages of 18 and 65 years.
20. Give names, strengths, doses and route of administration of investigational drugs to be used: 
Not applicable
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21. Are the drugs to be used subject to the terms of>
A Product Licence:
A Clinical Trial Certificate (CTC) or Certificate Exemption (CTS): 
Is an unlicensed Product, but is registered under the DDX Scheme: 
Not applicable
Which ever is applicable, please provide documentary evidence:
22. Are the drugs used being given in accordance with the Product Licence, with the agreed 
protocol (in the case of CTX or DDX) or with the CTC?
Not applicable
If no, give details:
23. Which manufacturer is organising the trial or supplying investigational drugs? 
Not applicable
24. If the trial is being undertaken in general practice and involves the supply of drugs, please 
state the arrangements for storage, labelling and dispensing.
Not applicable
25. Are questionnaires to be used? If yes, a copy must be attached to this application form. 
Copies attached
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26. How is the project to be funded?
Self
27. Please state any ‘interests’, ie. profit, personal or departmental, financial or otherwise, 
relating to the study. Details of payments per patient recruited, and/or any other 
remuneration details must be included.
Not applicable
28. Will the research have revenue consequences for the NHS? If yes, please tick the box(es) 
applicable below:-
Nursing
Pharmacy
Medical Records
Laboratory services
Other clinical services of the Trust
If you answer yes to any of these, please give details of the revenue consequences.
Not applicable
29. Please attach other relevant material: for instance, letters to subjects (which must be in 
simple non-technical language).
Not applicable
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The information supplied above is to the best of my knowledge and belief accurate. I have read the 
notes to investigators and clearly understand my obligations and the rights of the subject, particularly 
in so far as to obtaining freely given informed consent. I also confirm that I have read and 
understood “The Declaration o f Helsinki ”
Date of Submission: 2nd December 1996
Signature of Principal Investigator:_______ _________________________
Finally, please ensure that you have enclosed, if appropriate:
- Questionnaires
- Letters to General Practitioners
- Letters, information sheets, for the participants
- Copies of consent forms
- Copy of protocol
- Documentation relating to drugs
- Any other material which you think is of relevance to your application
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3. MAJOR RESEARCH PROJECT PAPER
Disulfiram treatm ent, self-efficacy and the cue exposure hypothesis
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Summary
Aims. To explore the cue exposure hypothesis which predicted an increase in self-efficacy and a 
reduction in craving in clients who continued to receive disulfiram treatment. Design. Measures 
were taken at the beginning of treatment and at 3 and 6 months follow-up. Clients who continued 
disulfiram treatment were compared with those who discontinued. Setting and participants. A 
total of 56 consecutive attenders at Alcohol Problems and Treatment Units, who were undergoing 
disulfiram treatment, took part in the study. Findings. There were no reported changes in self- 
efficacy or craving during the period of study, in either group. Reported levels of self-efficacy were 
low at treatment outset and remained low at 3 and 6 months. Conclusions. History of chronic 
alcohol abuse and associated problems may have mitigated against short-term changes. Clients in 
both groups failed to confront high-risks situations. Further studies are required to test the cue 
exposure hypothesis.
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Introduction
One of the most promising perspectives within the field of problem drinking is self-efficacy theory. 
It is defined as an individual’s appraisal of his/her ability to perform a certain behaviour and has 
been hypothesised as a central factor mediating change in human behaviour (Bandura, 1977). The 
strongest support for self-efficacy theory, as applied to addictive behaviours, can be found in the 
smoking cessation literature (Baer, Holt & Lichenstein 1986; Condiotte & Lichtenstein, 1981). 
More recently, empirical research evaluating the tenets of self-efficacy theory as applied to treatment 
for alcohol problems has begun to appear. The results of studies have shown some consistencies and 
some support for self-efficacy theory. An increase in self-efficacy has consistently been found from 
treatment intake to treatment completion (Burling et a/., 1989; Rychtarik et al., 1992) or follow-up 
(Annis & Davis 1988; Solomon & Annis, 1990). Subjects who have not relapsed at short-term 
follow-up of 3 to 6 months show higher levels of self-efficacy than do individuals who have relapsed 
(Burling et al., 1989; Solomon & Annis, 1990). Burling et al. (1989) also found that individuals 
who maintained abstinence through 6 months exhibited a significantly greater increase in self- 
efficacy from intake to discharge compared to those who did not maintain abstinence. The results of 
these studies suggest that self-efficacy may play a role in determining outcome, however, the 
strength of the self-efficacy effect, its implications for longer term outcome and its interaction with 
other behavioural interventions require further investigation.
Supervised disulfiram treatment is included in Heather’s (1993) revised list of behavioural 
interventions which show evidence of effectiveness. In a review of the disulfiram literature, Brewer 
(1993) concludes that “the evidence for the effectiveness of supervised disulfiram has been 
accumulating since 1967, with no contrary findings” (p. 34). He has also suggested that one of the 
ways disulfiram treatment might effect longer-term changes is by enabling the individual to confront 
situations which are high-risk for relapse while forcibly preventing drinking from taking place (i.e. 
cue exposure and response prevention). It would be expected that craving responses associated with 
external and internal stimuli will be extinguished and that self-efficacy (i.e. confidence in coping 
with the high-risk situation) will be increased. Heather (1993) has argued that this hypothesis, if 
valid, would offer an explanation of how disulfiram might result in behavioural changes which 
persist beyond the disulfiram treatment. (Literature Review p. 7). He highlights two problems; the 
first is the possibility that the extinction of conditioned craving responses only takes place when the 
drinking response is available. Thus, the individual must be exposed to temptation for extinction to 
occur and temptation may have been removed or reduced by the knowledge that disulfiram has been 
taken. Secondly, he suggests that for self-efficacy to be increased, the individual must be able to 
attribute the success of coping efforts in high-risk situations to him/herself. When disulfiram has 
been taken, the credit for coping may be attributed to an external agency (i.e. disulfiram). Heather 
(1993) concludes that even if the cue exposure hypothesis of disulfiram’s action is incorrect, then the
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least that disulfiram is likely to do is to offer respite, improvement in physical health and a break in 
the cycle of problems and drinking. He nevertheless argues that Brewer’s hypothesis and the two 
objections that he has raised are ‘eminently researchable’ (p. 15) among those undergoing disulfiram 
treatment.
The current study aimed to investigate the relationship between self-efficacy theory and disulfiram in 
a sample of problem drinkers who were undergoing disulfiram treatment. Exposure to high risk 
situations and craving was also investigated. The following hypotheses were examined.
Hypotheses
1. Compared to those who discontinued disulfiram treatment, those clients who remained on 
disulfiram treatment would show increases in self-efficacy from intake to post-treatment.
2. Clients who remained on disulfiram treatment and have experienced more high-risk situations 
would have higher self efficacy scores.
3. Compared to those who discontinued disulfiram treatment, clients who remained on disulfiram 
treatment would report a reduction in craving from intake to post-treatment..
Methods
Subjects
The study was carried out at Alcohol Problems and Treatment Units in Greater Glasgow Community 
Mental Health Services NHS Trust and Renfrewshire Community Mental Health Services NHS 
Trust. Problem drinkers who took part in the study were consecutive attenders who had commenced 
disulfiram treatment. Fifty-seven patients were asked to take part in the study, and one refused. 
Patients were either receiving disulfiram for the first time or were beginning a new episode of 
treatment.
The Interview Schedule
In all cases data were collected by interview. This took place at the beginning of treatment and was 
repeated at 3 and 6 months. The interview schedule was pre-tested on a sample of 6 patients who
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had been established on disulfiram treatment for several months. Two changes were made to the 
interview schedule following the pilot study. Firstly, a questionnaire that measured high risk (for 
drinking) situations (Inventory of Drinking Situations; Annis, Graham & Davis, 1987) was modified 
to provide a structured way of recording a clients exposure to high risk situations. Secondly, it was 
decided to use a generalised self-efficacy measure. Two alcohol-related self-efficacy measures had 
been tested during the pilot, however, the self-efficacy being measured and the criterion measure of 
behaviour did not correspond. The Situational Confidence Questionnaire (SCQ) (Annis & Graham, 
1990) inquires about ability to resist the urge to drink heavily and measures control self-efficacy 
rather than abstinence self-efficacy. The Alcohol Abstinence Self-Efficacy Questionnaire (AASES) 
(Diclemente, Montgomery & Hughes, 1993) assesses efficacy to abstain from drinking but includes 
several questions that made it unsuitable for clients receiving disulfiram treatment. For example, 
one question asks about confidence regarding not drinking whilst withdrawing from alcohol, another 
asks about confidence when faced with the urge ‘to try just one drink to see what happens’. This is 
inconsistent with the criterion for disulfiram treatment.
The following measures were taken:
1. Demographic information including age, sex, employment and marital status.
2. Length of drinking history, and number of abstinent days during the 6 months prior to 
treatment.
3. The Severity of Alcohol Dependence Questionnaire (SADQ) (Stockwell, Murphy & Hodgson, 
1983). This was used to measure physical dependence on alcohol. It consists of 20 items each 
scored on a four point scale. A score of 30 and below indicates mild to moderate dependence, 
while a cut-ofF point of 31 and above indicates severe dependence. Disulfiram treatment is 
more likely to be offered to clients who have a severe dependence.
4. The General Health Questionnaire (GHQ) (Goldberg & Hillier, 1979). The 28 item version of 
this screening instrument, which rates items on a four point scale, was used. It comprises four 
sub-scales measuring somatic symptoms, anxiety and insomnia, social dysfunction and severe 
depression; a threshold score of five and above indicates caseness. There are formidable 
methodological problems in measuring these disorders in problem drinkers, because of the 
overlap of withdrawal symptoms being measured. This measure was included to explore the 
relationship between psychological distress, compliance with disulfiram treatment and self- 
efficacy.
5. Inventory of Drinking Situations (EDS) (Annis et al., 1987). The 42 item questionnaire 
provides a profile of an individual’s high-risk for drinking situations. Clients were asked to rate 
each situation or event retrospectively in terms of whether or not they drank heavily. Responses 
are on a four point scale ranging from ‘never’ (1) to ‘almost always’ (4).
6. Revised Inventory of Drinking Situations (RIDS). Following the pilot study, the EDS was 
modified to allow clients to rate whether or not they had felt like drinking in specific situations.
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Responses are on a four point scale ranging from ‘never’ (1) to ‘almost always’ (4) .This 
measure was used at 3 and 6 months follow-up. A copy of the IDS and the RIDS can be found 
in Appendix 1.
7. The Generalized Self-efficacy Scale (GSES) (Schwarzer & Jerusalem, 1993). The score on this 
10 item scale reflects the strength of an individual’s generalised self-efficacy beliefs. 
Respondents were asked to indicate the extent to which each statement applied to them along a 
four point scale from ‘not at all true (1) to ‘exactly true’ (4).
8. Craving Index (Cl) (West et al., 1984). This is a 5 item visual analogue scale which was 
adapted by the author for alcohol use. Questions relating to cigarettes and smoking were altered 
by inserting the word alcohol or drinking. Measures of subjective craving for alcohol range 
from ‘not at all’ (1) to ‘quite a lot’ (5). A copy of the modified questionnaire can be found in 
Appendix 1.
To provide corroborative evidence regarding compliance, blood tests were taken at the beginning of 
treatment and at 6 months follow-up. These included serum gamma-glutamyl transferase (GT) and 
mean red cell volume (MCV) which are markers of regular alcohol consumption (Chick, Kreitman 
& Plant, 1981). Only the gamma GT will be reported.
Compliance was also measured by interviewing client’s keyworkers at 6 months follow-up. 
Supervision of disulfiram treatment is standard practice in APTU’s and is normally provided by a 
keyworker. The client is asked to attend the APTU three days per week and take disulfiram under 
supervision. If a partner or person with whom the client has regular contact is undertaking 
supervision then procedures are clarified in advance and the keyworker will support both client and 
supervisor.
Statistical analysis
All data were analysed using SPSS 7.5.
Results
Sociodemographic information
The sample consisted of 41 men and 15 women. The average age was 43 years, with a range from 
25 to 66 years. Sixteen (26%) of the sample were employed, a further 32 (57%) were unemployed, 
or retired and 10 (17%) described themselves as housewives. Twenty-three (42%) were married 
with 13 (23%) either divorced or separated and 16 (35%) single. These figures are similar to the
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sociodemographic characteristics of consecutive attenders to an Alcohol Problems and Treatment 
Unit (APTU) described by Allan (1991).
Alcohol dependence and related problems
Thirty-seven (66%) scored 30 or above on the SADQ (mean = 35.6; S.D = 13.2), indicating severe 
dependence. A history of problem drinking of more than 20 years duration was reported by fifteen 
(27%) clients and between 10 and 20 years by twenty-seven (49%), the remaining fourteen (25%) 
reported a drinking history of between 1 and 10 years. The mean GHQ score for the group (N = 56) 
was 7.8 (SD = 7.2) and thirty-seven (66%) clients obtained a score of five or more on the GHQ at the 
time of initial interview, indicating high levels of psychological distress.
A total of thirty-two (58%) clients were interviewed at six months follow-up. Of these, fifteen (27%) 
had remained on disulfiram throughout the study period and seventeen (31%) had stopped taking 
disulfiram. The latter included three who had to be withdrawn because of adverse reactions (two 
owing to allergic skin rash, one with nausea). Among the twenty-four (43%) remaining clients, two 
had moved away from the area, two were in a residential alcoholic treatment centre and one was in 
prison. The remaining nineteen (34%) failed to keep appointments. Those who defaulted did not 
differ from the total treatment group in terms of age, sex or marital status, however, a higher 
proportion were unemployed (16). Numbers were insufficient to test this statistically.
Self-efficacy: changes from pre to post treatment
It was hypothesised that clients who continued disulfiram treatment would show increases in self- 
efficacy scores (GSES), from intake to post-treatment, compared to those who discontinued 
disulfiram treatment. A comparison was made between the continued and discontinued group. The 
GSES scores are shown in Table 3.1.
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Table 3.1 GSES scores for groups (continued, discontinued) at 0, 3 and 6 months post­
treatment (means; SD)
Dilsulfiram status GSES GSES GSES
0 month 3 months 6 months
mean (SD) mean (SD) mean (SD)
N N N
Continued treatment 23.6(8.5) 24.4(7.9) 26.7(7.4)
15 13 15
24.4 (5.7) 26.3 (4.9) 26.7 (5.4)
Discontinued treatment 20 16 17
A repeated measures analysis of variance was performed with group (continued, discontinued) as the 
between-subjects independent variable and self-efficacy scores as the within-subjects dependent 
variable. There was no significant interaction effect between group and self-efficacy (F(2.52) = 
0.181; NS). There was also no significant main effect for group (F(l,26) = 0.139; NS), nor was 
there a significant main effect for self-efficacy (F(2.52) = 1.569; NS). This means that there was no 
increase in self-efficacy scores from intake to post treatment on this measure. Mean scores on the 
GSES for both groups (continued, discontinued) were below the normative data (29.28; S.D.= 4.6) 
reported by Schwarzer and Jerusalem (1993).
Self-efficacy and exposure to high-risk situations
The second hypothesis stated that there would be an association between exposure to high risk 
situations (IDS/RIDS) and self-efficacy scores (GSES) among those clients who continued, compared 
to those who discontinued disulfiram treatment. This was examined through a correlational 
analysis, using scores obtained initially and at both follow up periods. The correlations between 
(IDS/RIDS) and (GSES) ranged from (.048) to (.163). None was significant at the 5% level. There 
were no significant correlations between high-risk situations and self-efficacy scores at 0, 3 and 6 
months.
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Table 3.2 Scores of high-risk situations (IDS/RIDS) with scores of self-efficacy (GSES) for 
‘continued’ group (Pearson’s correlation)
IDS GSES GSES GSES
0 month 3 months 6 months
0 months 0.048
3 months (a) 0.163 0.092
6 months (a) 0.090
Craving
The third hypothesis was that those who continued disulfiram treatment would experience a decrease 
in craving (Cl) from intake to post-treatment compared to those who discontinued treatment. Scores 
on Cl at 0, 3 and 6 months for both groups are shown in Table 3.3
Table 3.3. Cl scores for groups (continued, discontinued) at 0, 3 and 6 months 
(means; SD)
Disulfiram status Cl 0 month Cl 3 months Cl 6 months
mean (SD) mean (SD) mean (SD) 
N N N
Continued
treatment
15.9 (7.2) 
15
15.0 (7.1) 
13
13.5(6.3)
15
Discontinued
treatment
16.85 (5.3) 
20
17.25 (6.1) 
16
17.2 (5.7) 
17
A repeated measures analysis of variance was performed with group (continued, discontinued) as the 
between-subjects independent variable and Cl as the within-subjects dependent variable. There was 
no significant interaction effect between group and Cl (F (2.52) = .183; NS). There was also no 
significant main effect for group (F( 1.26) = 1.64; NS), nor was there a significant main effect for Cl 
(F(2.25) = .818; NS). This means that those continuing treatment did not report a reduction in 
craving from intake to post-treatment on this measure.
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Psychological distress, attributing success and avoidance
A significant negative correlation was found between GSES and GHQ (0.281, p< 0.05), suggesting 
that higher levels of psychological distress are related to lower levels of self-efficacy.
At 6 months follow-up the ‘continued’ group were asked to provide percentage ratings that reflected 
the extent to which they attributed the success of remaining abstinent to themselves and the extent to 
which they attributed success to disulfiram. The mean percentage scores were (33.83, SD = 29.44) 
to self and (52.83, SD = 33.59) to disulfiram. This meant that those who had been successful in 
maintaining abstinence whilst undergoing disulfiram treatment attributed more of the success to 
disulfiram than to themselves. It was not possible to put this question to the ‘discontinued’ group. 
When clients were asked about use of coping strategies when taking disulfiram, twenty-two (39%) of 
the total number of clients interviewed at 6 months (N = 33) reported avoidance of high-risk 
situations. Thirteen (23%) of these clients were in the ‘continued’ group (N = 15).
Treatment outcome
Both groups achieved a reduction in alcohol consumption. During the 6 months prior to treatment, 
mean abstinent days for the ‘continued’ group were 47.87 (SD = 49.06) increasing to 179.60 (SD = 
1.30) during the 6 month treatment period. For the ‘discontinued’ group, number of mean abstinent 
days increased from 20.20 (SD = 30.78) to 88.72 (SD = 48.77). Using Student’s i-test, there was no 
significant difference between groups at treatment outset. There was a statistically significant 
difference between groups at 6 months follow-up (p < 0.05).
Corroborative evidence
Both initial and final blood samples were available for only 12 (22%) of the clients in the 
‘continued’ group and 11 (20%) of the discontinued group because some were unable to attend when 
staff were available to take samples. Mean serum GT levels in the ‘continued’ group reduced from 
141.9 (SD = 142.0) at the beginning of treatment to 20.5 (SD = 10.0) at 6 months follow-up. Pre 
and post samples in the ‘discontinued’ group were 154.72 (SD = 150.7) and 94.6 (SD = 100.3). At 6 
months follow-up all clients in the ‘continued’ group had serum GT levels within the normal range 
(5-50), compared to only four clients in the ‘discontinued’ group. It was confirmed by APTU staff 
that 10 (18%) of the ‘continued’ group attended for regular supervision of disulfiram treatment. 
Three (5%) were supervised by partners and two (4%) were unsupervised but maintained regular 
weekly contact with the APTU.
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Discussion
The results of the study run counter to the view that disulfiram treatment leads to an increase in self- 
efficacy. The results also failed to support the extinction hypothesis since no reduction in craving 
was found among clients who remained on disulfiram treatment.
One important finding was that regardless of whether or not clients continued or discontinued on 
disulfiram treatment, there was no change in self-efficacy from intake to post-treatment. There could 
be several reasons why the hypothesis was not confirmed. The sample comprised a group of chronic 
problem drinkers, the majority of whom reported long histories of alcohol abuse. This is likely to 
have mitigated against any short-term changes, and change in self-efficacy may have been detected 
with a longer follow-up period. The group are likely to have experienced a range of problems and 
past failures and it is perhaps not surprising that they reported persistently low levels of self-efficacy. 
Identification of clients with low self-efficacy and high levels of psychological distress would seem 
important. In the present study, the GHQ was only measured at treatment outset; it could have been 
informative if this measure had been repeated at 3 and 6 months. Intervention techniques based on 
cognitive behavioural methods may improve self-evaluation and psychological distress in such 
clients. For optimal effect, this should be offered concurrently with disulfiram. Another reason why 
self-efficacy may have failed to increase in the manner predicted by the experimental hypothesis was 
that the majority of those who continued disulfiram treatment attributed a greater proportion of the 
success of coping to an external agency (i.e. disulfiram). Heather (1993) hypothesised that for self- 
efficacy to increase, the client must be able to attribute the success of coping efforts in high-risk 
situations to him/herself.
A majority of clients in both groups reported avoidance of high risk situations. Confronting high- 
risk situations is central to the self-efficacy hypothesis and there is unlikely to be an increase in self- 
efficacy when clients are using avoidance as a coping strategy. Heather (1993) suggested that 
repeated ‘mastery experiences’ of confronting high-risk situations (with the aid of disulfiram) would 
lead to greater self-efficacy in coping with those high-risk situations in future. The avoidance of 
high-risk situations has implications for the extinction hypothesis. This stated that unreinforced 
exposure would lead to the extinction of conditioned craving responses and a reduction in craving. 
This view of disulfiram considers it a form of cue exposure and response prevention, similar to 
methods used to treat phobic and obsessive-compulsive disorders. Since exposure failed to occur in 
the majority of cases, however, the hypotheses have not been adequately tested. If disulfiram 
treatment is to bring about an increase in self-efficacy and a reduction in craving, then exposure has 
to be an essential component of treatment. A future study could ask one group of clients receiving 
disulfiram treatment to enter high risk situations and compare it with another group who are asked 
to avoid situations involving high-risk. This may be a more effective test of the hypotheses,
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however, the nature of the treatment and the vulnerability of this client group is likely to present an 
ethical problem.
Finally, there may have been no change in reported self-efficacy because the GSES is a measure of 
generalised rather than alcohol related self-efficacy and may not have been specific enough to tap 
into alcohol related increases in self-efficacy. While there are problems with existing alcohol-related 
self-efficacy measures, it should be possible to modify or develop a more suitable instrument. 
Goldbeck, Myatt & Ailchison (1997) have recently developed the Self-Efficacy Questionnaire which 
is a global measure of self-efficacy that specifically refers to abstinence as the chosen outcome goal. 
This may prove to be more appropriate for a disulfiram treatment group and could be considered for 
future studies in this area.
Conclusion
Although the present study has failed to find evidence for the self-efficacy and cue exposure 
hypotheses, several important issues have been raised. Contrary to what had been predicted, clients 
did not use disulfiram to confront high-risk situations. The majority reported using avoidance as a 
coping strategy, consequently, the study has not been a true test of the hypotheses. An important 
finding was that clients reported low levels of self-efficacy regardless of whether they had been 
successful or unsuccessful in complying with disulfiram treatment. Reasons for this have been 
outlined, however, this is an area that deserves further investigation. We need to know how 
disulfiram treatment is affected by co-existing conditions and levels of psychological distress and 
how assessment and treatment offered concurrently could improve outcome. If we eventually 
discover that the hypotheses of disulfiram’s action proves to be correct, then we need to know how 
and to what extent we can facilitate the process.
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4. SMALL SCALE SERVICE EVALUATION PROJECT
Disulfiram Treatm ent for Alcohol Problems: Consum er Feedback
This chapter was written according to the guidelines of Psychiatric Bulletin 
A copy of the instructions to authors can be found in Appendix 2.
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Introduction
A prominent feature of the Government White Paper “Designed To Care” (1997) is the renewed 
emphasis on examining the health service from the perspective of patients. Seeking consumers’ views 
of services and involving them in decisions about treatment could improve treatment uptake and 
compliance and modify care practice. The results of a survey of disulfiram treatment for alcohol 
problems is presented.
Central to the objective of renewal of the National Health Service is the philosophy that,
“every aspect of the planning and delivery of services
should be designed from the perspective of the patient” (section 2,14).
One of the stated aims of The Government White Paper “Designed To Care” is to provide better 
services for patients in ways that are “responsive to their needs and wishes” (section 2,12). Previous 
reports (DHSS, 1983; DoH, 1989; Kerruish, Wickings & Tarrant, 1988) have all emphasised the 
importance of obtaining the opinions of users and of using this information to monitor performance 
and guide policy. Within the climate of the internal market, this has sometimes been interpreted as 
seeking the views of the purchasers of services (Duff, 1995; Stallard & Hudson, 1993). The 1997 
report, however, takes as a starting point the perspective of patients. It states that priority should be 
given to the examination of services from their point of view with the aim of implementing change 
designed to enhance their experience of the NHS.
This renewed emphasis on the patient’s perspective is likely to provide opportunities for patients who 
have hitherto not always been the focus for patient satisfaction surveys and have rarely had their views 
documented. Within the field of mental health, there has been little interest to date in addressing the 
views of the more transient and shifting out-patient population, who tend to be inconsistent in their 
use of the service and/or find it difficult to comply with treatment demands (Ralston, Beesley & 
Bogue, 1998; Torrens & Harris, 1996). There have also been very few studies of minority groups both 
in terms of patient and of treatment characteristics (Carr-Hill, 1992).
Patients with an alcohol problem are one group who present a particular challenge to service 
providers because of their high relapse rate and the problem this creates for the delivery of treatment. 
According to Fitzpatrick (1991), there are several reasons why consumers views are essential to 
service providers. Firstly, it has been demonstrated that satisfaction is an important outcome measure 
in influencing treatment compliance. Secondly, satisfaction can provide a measure of assessing 
consultations and patterns of communication such as the provision of information and the 
involvement of the patient in decisions about care and, finally, patient feedback can be used to modify 
or propose alternative care practices.
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Background
Since its introduction in the late 1940’s, the alcohol sensitising drug disulfiram (Antabuse) has been 
used in the treatment of alcohol problems. Disulfiram is an agent which inhibits the metabolism of 
alcohol, resulting in the unpleasant symptoms (flushing, headache, nausea, dizziness, tachycardia) of 
the disulfiram-ethanol reaction (DER). The rationale of the treatment is that a patient cannot drink 
while taking disulfiram and will only have to make one daily decision to take the medication rather 
than have to resist a sudden urge or temptation at any moment to drink. In the largest study to date of 
disulfiram treatment, Fuller et al. (1986) found that patients who had received disulfiram, had 
significantly fewer drinking days than patients in control groups. The latter had received either a 
pharmacologically inactive dose of disulfiram or a riboflavin tablet. There were no significant 
differences between groups in total abstinence or time to first drink. Fuller et al. (1986) concluded 
from their results that disulfiram may help to reduce drinking frequency following relapse, but does 
not assist problem drinkers to maintain abstinence or delay relapse. Those who had improved in all 3 
groups however were those who had complied best with treatment. A conclusion from Fuller et a l 's 
(1986) study was:
“The effectiveness of disulfiram in promoting abstinence was limited
because the majority of patients did not take disulfiram regularly” (p. 1454).
The conclusion that the chief problem in disulfiram treatment is one of patient compliance has been 
noted by many workers in the field including Heather (1993). He cites a range of studies in addition 
to the major work by Azrin (1976), which have demonstrated that supervised disulfiram is superior to 
unsupervised disulfiram. There is also evidence relating to effectiveness among clients who had 
already failed in treatment by other methods (Sereny, Sharma & Holt, 1986/ Ways of increasing 
compliance with disulfiram treatment continue to be sought. Even if patients are unable to achieve 
total abstinence with disulfiram treatment, the benefits in terms of harm reduction are of great 
interest. At the very least, a successful episode of disulfiram treatment can provide the patient with a 
respite from the ravages of heavy drinking - an improvement in physical health and a break in the 
vicious circle of mounting personal and social problems (Heather, 1993). A desire to maximise the 
window of opportunity that disulfiram treatment offers by improving treatment delivery and patient 
compliance prompted the present study.
The Study
The aim of the study was to investigate the views of patients who are receiving disulfiram from 
alcohol treatment services within Greater Glasgow Community and Mental Health NHS Trust. A 
questionnaire was devised specifically for the study, as at that time no existing standard measure was
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appropriate. It consisted of 14 questions, 9 forced-choice and 5 open-ended, including a final 
question that invited comments on disulfiram treatment. When the questionnaire was being 
compiled, two of the issues raised by Stallard & Harris (1993) regarding consumer evaluation, were 
addressed. The first was that satisfaction questionnaires should relate to a specific treatment, since 
overall general ratings of satisfaction tend to be meaningless, providing no clear information about 
which aspects of the service are positive and which need to change. The second was that consumer 
evaluation questionnaires frequently consist of items which the researchers consider to be important. 
Consumers typically have little involvement in determining pertinent variables, which questions the 
validity of such measures. In line with Stallard & Harris (1993) recommendation, consumers were 
consulted regarding what was required and the questionnaire was piloted to confirm its suitability.
The questionnaire was designed to gather information regarding four aspects of disulfiram treatment. 
The first was concerned with prior experiences and knowledge of disulfiram. The second related to 
treatment delivery. Employing concurrent therapies was addressed in part three and patients were 
asked to rank, according to preference, a list of 6 therapies. Finally, questions regarding the use of 
disulfiram per se were the focus of part four. A total of 57 patients1 attending alcohol treatment 
services over a 6 month period, who were receiving disulfiram treatment, took part in the study. 
Questionnaires were anonymous and distributed by staff members who were uninvolved with the 
study. A copy of the questionnaire is provided in Appendix 2.
Results
Prior Knowledge and Understanding
Sixty-eight percent reported that they had first heard about disulfiram from the alcohol treatment 
services, 12 % from an unnamed “other” source and 10% from their G.P. The remainder had heard 
through other alcohol problem patients (5%) or a friend (3%). The mean time receiving disulfiram 
was 7 months (range: 1 to 24 months). Fifty percent of the respondents had previously received 
disulfiram treatment.
Treatment delivery
Ninety-one percent reported satisfaction with the information received prior to commencing 
treatment. Almost 74% were having their disulfiram treatment supervised, the majority (47%) by 
APTU staff. Only 16% were receiving supervision from a spouse/partner, 5% from a G.P., 5% from
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an unnamed “other” source and 1.8%, i.e. one individual from a local pharmacist. Ninety-one percent 
of patients felt satisfied with the number of follow-up appointments, 9% considered these were too 
few.
Concurrent therapies
Thirty-seven percent were receiving additional therapy which comprised individual counselling 
and/or self-help groups, including 2 patients who were attending Alcoholics Anonymous (AA). The 
remaining 63% were receiving no additional treatment/therapy. Question 12 enquired about 
preferences for therapy/treatment to be offered with antabuse. Patients were asked to rank a list of 6 
therapies in order of preference. Thirty-three per cent chose individual counselling and support as 
their first choice, 19% chose a support group, 12% thought education about the harmful effects of 
alcohol should have priority while help with life-style changes and training in coping skills regarding 
high-risk situations were first choice for 10% and 7%, respectively. Relaxation training was first 
choice for 1.8% (i.e. only one patient). The preferred order in which the forms of therapy/treatment 
were ranked can be found in Table 4.1.
Disulfiram Treatment
Forty-two percent thought that supervision of antabuse treatment (question 8) had been helpful. Some 
(7%) thought it had led to an increase in confidence regarding their ability to deal with alcohol whilst 
others (5%) stated that it removed the decision about drinking. Only 9% responded to question 9, 
which was concerned with unhelpful aspects of antabuse treatment. The majority of these felt that 
taking disulfiram had undermined their confidence. Unpleasant side-effects (question 10) were 
reported by 32%, including metallic taste, bad breath and lethargy. Several others (7%) reported that 
the only unpleasant side-effects they had experienced were after drinking alcohol, whilst on antabuse. 
In response to the question “How has antabuse helped you to remain abstinent?”, 54% felt that it was 
the deterrent aspect of the treatment that was effective. Comments here related to the “fear factor” of 
an alcohol/antabuse reaction, to antabuse “buying time” and being the “only solution”. A few referred 
to the benefits of having more money and more opportunity for leisure activities as a result of being on 
antabuse treatment. The invitation for additional comments was taken up by relatively few patients 
(7%). Comments concerned fear of being on long-term medication and fear associated with 
eventually having to stop disulfiram.
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Discussion
This paper has presented the results of a survey of patient satisfaction with disulfiram treatment. 
Results indicate that patients were generally satisfied with the treatment they received. Consumer 
surveys typically describe high rates of reported satisfaction. Damkot, Pandiani & Gordon (1983) 
found that the majority achieved a 70-90 percent satisfaction rate. Chadwick & Stallard (1991) 
suggest that these figures are likely to be affected by the rate of return, which is typically between 50 
and 60 per cent. The present study differs in that patients were invited to complete the questionnaire 
when they attended for outpatient review. Fifty seven of the 58 patients approached completed the 
questionnaire. The results therefore represent a wider range of views of patients who receive 
disulfiram treatment and not only those inclined to return questionnaire forms. Restricting the survey 
to clinic attendees only, inevitably excluded the views of those patients who dropped out of treatment 
prior to their first follow-up appointment. Information from this group could be useful in helping to 
address the needs of the more ambivalent patient. It was decided, however, that patients required a 
minimum of six weeks experience of disulfiram before their views of the treatment should be sought.
In the present study, 68% of respondents reported that they had first heard of disulfiram from the 
Alcohol Problems and Treatment Unit (APTU) with only 10% having heard from their G.P. This 
supports Brewer’s (1993) finding that despite evidence that disulfiram, when taken under supervision, 
is a treatment whose effectiveness has been consistently demonstrated, its use in the management of 
alcohol abuse is far from universally accepted. Heather (1993) has suggested that disulfiram has 
become generally unpopular because it is seen as a drug treatment associated with an outmoded 
“medical model of alcoholism” (p. 471). Cognitive and behavioural methods for modifying drinking 
behaviour have been increasingly used and it has been suggested that disulfiram should be classified 
as a behavioural intervention rather than a medical treatment (Heather, 1993). The “medical” feature 
about disulfiram is the fact that it legally requires a medical qualification to prescribe and monitor its 
use. Another view proposed by Brewer (1993) is that disulfiram treatment has become unpopular 
because of exaggerated fears of side-effects and the DER. Alcoholics Anonymous regard it 
pejoratively as a “crutch” and this may also have influenced its use. Patients may feel more confident 
about disulfiram treatment and view it more positively if encouraged to do so by their G.P. or other 
health professionals. They are also likely to benefit from intervention at an earlier point in their 
drinking career before the onset of major physical and social problems. G.P.’s are well placed to offer 
early assessment and treatment of alcohol problems and may be encouraged to do so if the benefits of 
treatment were promoted and the myths challenged. Seventeen percent of the respondents had 
remained on disulfiram treatment for a period of between one and two years. Fifty per cent had 
previously received at least one episode of disulfiram treatment. This suggests that it is acceptable as 
a longer term maintenance treatment for a proportion of the alcohol abusing population and that 
patients are willing to resume disulfiram treatment following relapse.
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The adverse effects of the DER are well known therefore patients are counselled prior to commencing 
disulfiram treatment and provided with written information concerning treatment and future 
management. A high level of patients (91%), reported satisfaction with the information received 
prior to commencing treatment and with the number of follow-up appointments offered. Only 9% felt 
that the information was insufficient and the follow-up appointments too few. Although the benefits 
of having medication supervised are emphasised and partners are encouraged where possible to be 
involved, 25% of patients were receiving no supervision. Forty-seven per cent were receiving 
supervision from APTU staff and only 16 % were being supervised by a partner or spouse. Difficulty 
in establishing a supervision agreement with the latter, may reflect a tendency to offer disulfiram 
Ireatment at a relatively late stage in a drinking career when relationships have broken down and 
there is less likelihood of partner involvement. Azrin et al. (1976) found that supervision by wives 
was significantly superior to unsupervised use however a form of contract was used and treatment was 
embedded within a “community reinforcement approach” that involved work, family and social 
relations.
When asked to rank six alternative therapies in order of preference, individual counselling and 
support received the highest first choice ranking (33%). Relaxation training received the lowest 
(1.8%). Training in coping skills regarding high-risk situations was ranked first by only 7% (see 
Figure 4.1). Since tliis therapy is not routinely delivered in APTU’s, this may be reflecting a lack of 
knowledge regarding what is involved. Skills training has been shown to be an effective treatment for 
alcohol abuse and is included in Heather’s (1993) list of effective treatment methods. Individual 
counselling is confined to an alternative list of treatment methods that have not been supported in 
controlled outcome studies, although they are standard practice in APTU’s. A future study could 
describe the content and aims of the various treatment options prior to asking patients to rate 
importance. Informing patients in this way could yield a very different set of choices.
Figure 4:1 here
The open-ended questions provided insight into individual views of the benefits of disulfiram 
treatment. There were few reports of anxiety or concern regarding its use. In line with an earlier 
view proposed by Heather (1989), it is the “deterrent effect of disulfiram rather than its 
pharmacological effect that is important” (p. 471). Sixty percent of the patients acknowledged that 
this was the case.
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Conclusion
The basic assumption underlying the present study is that consumers of services should routinely be 
involved in voicing their opinions with the services they have received and that this feedback should 
lead to change, where necessary. Involving consumers in the evaluation of services however raises a 
number of issues that need to be considered if we are to obtain meaningful information upon which 
treatment services can develop. One of the issues that has arisen in the present study, is the 
importance of ensuring that patients are in a position to make an informed choice about other 
treatment Options. This is vital and an essential pre-requisite for optimal patient care. Another issue 
concerns the way in which patients have access to treatment. For example, Heather (1989) has argued 
that more attention should be paid to supervised disulfiram since treatments of proven effectiveness 
are few and “desperately needed” (p. 299). Supervised disulfiram has been shown to be effective and 
should be readily accessible and not confined to specialist services. The latter may need to find more 
effective ways of informing and collaborating with primary care services. This will be an essential 
part of the process, if our ultimate goal is to implement change designed to enhance consumers’ 
experience of the NHS.
1 Clients who took part in the audit project formed a different sample from those who took part in the 
Major Research Project.
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Figure 4.1 Treatment preference o f disulfiram clients 
Treatment options:
1 individual counselling and support
2 relaxation training
3 training in coping skills and dealing with high-risk situations
4 support group
5 education about the harmful effects o f alcohol
6 lifestyle changes
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4.1 Post Traumatic Stress Disorder with Headache Pain
Summary
Studies have shown that post-traumatic stress disorder is commonly found among patients who 
present with headache pain following a road traffic accident. A case involving the cognitive 
behavioural treatment of a man who was referred for assessment of headache pain following a road 
traffic accident is presented. Cognitive behavioural treatment was designed to target headache pain 
and post traumatic stress disorder. Substantial reductions in headache pain and post-traumatic 
symptoms were reported after 9 treatment sessions. This study highlights the importance of 
routinely assessing for PTSD with headache pain presentations.
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4.2 The Use of Imagery to Access Core Beliefs in Eating Disorder
Summary
An eating disorder treatment case is presented. Cognitive treatment was successful in eliciting and 
re-structuring automatic thoughts associated with food and body image, however, underlying 
dysfunctional assumptions and core beliefs were more intractable. The introduction of imagery and 
semi-structured probe questions as part of the cognitive component, proved to be an effective means 
of determining underlying core beliefs. Images appeared to reflect a wider range of idiosyncratic 
meanings than were apparent in the automatic thoughts alone.
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4.3 Comorbidity of Addictive Behaviours
Summary
Alcohol abuse frequently co-occurs within the context of other psychiatric disorders. The 
following treatment case describes a woman who presented with Obsessive Compulsive Disorder 
(OCD) and alcohol abuse against a background of chronic depressive illness. There was a 
substantial reduction in subjective distress associated with OCD symptoms following cognitive 
behavioural treatment. Relapse to excessive drinking, however, occurred during the course of 
treatment. The hypothesis that the alcohol problem was secondary to OCD was not supported. 
Relapse to excessive drinking occurred during a hypomanic episode which could not have been 
predicted. The study emphasises the importance of continued assessment with treatment cases 
involving comorbidity.
53
APPENDIX 1: MAJOR RESEARCH PROJECT PAPER
A uthor notes for Addiction............................................................................................ 55
Revised Inventory of Drinking Situations................................................................. 57
Craving Index...................................................................................................................60
54
Addiction
Guidance to Authors
The editorial s ta ff will be most grateful for your assistance in relation  to  the m a tte rs  listed below. 
Please follow this guidance carefully when p reparing  a submission.
G eneral m atters
Addiction is a refereed journal. Its goal is to serve international and interdisciplinary scientific and clinical 
communication, to strengthen links between science and policy, and to stimulate and enhance the quality 
of debate. Submissions are sought which are not only technically competent, but are original and contain 
information or ideas of fresh interest to our international readership. Books and major reports may be 
submitted for review, and material for the News and Notes section is welcomed. We seek to serve the 
developing as well as the developed world. We aim to handle submissions courteously and promptly, and 
welcome dialogue with our contributors and readers. We regret that we are not able to return manuscripts.
E thical standards
Manuscripts are accepted on the understanding that they are subject to editorial revision. Submissions must 
be accompanied by a signed statement from all authors saying that: (a) the material has not been published 
in whole or in part elsewhere; (b) the paper is not currently being considered for publication elsewhere; (c) 
all authors have been personally and actively involved in substantive work leading to the report, and will 
hold themselves jointly and individually responsible for its content; (d) all relevant ethical safeguards have 
been met in relation to patient or subject protection, or animal experimentation. This statement must also 
declare sources of funding, direct or indirect, and any connection with the tobacco, alcohol or pharmaceu­
tical industries. With regard to points (a) and (b): if data from the same study are reported in more than one 
publication, this should be stated in the manuscript and/or covering letter to the editor, along with a clear 
explanation as to how the submitted manuscript differs, and copies of closely related manuscripts reporting 
these data should be enclosed. If at any stage during the handling of their submission, authors decide to 
withdraw it, we ask them to notify the editor.
Length
Submissions should be double spaced and clearly legible. There is no maximum length for articles. We ask 
authors to be as concise as possible and will negotiate with you personally and sympathetically if we feel 
shortening would improve communication. Case reports are welcomed but should not be more than 6 pages. 
Letters should not be more than 2 pages.
L ayout
Please submit four copies of each manuscript. They should be typed on one side of the paper, double 
spaced, with margins of at least 25 mm. The first sheet should contain the title o f the paper, a short title 
not exceeding 45 characters, names of authors, the address where the work was carried out, and the full 
postal address of the author who will check proofs and receive correspondence and offprints. The second 
sheet should contain only the title, names of authors, and an abstract. Please send one extra loose copy of 
the abstract with submissions. The entire manuscript, including all references, tables, figures, and any other 
material, should be numbered in one sequence from the title page onwards. Please put at the bottom of the 
title page the total number of pages and, if possible, include a word count for the text and references 
(excluding title and abstract pages, tables and figures). Footnotes to the text should be avoided where 
possible.
A bstrac t
In the case of research reports, abstracts should use the following headings: Aims, Design, Setting, 
Participants, Intervention (experimental trials only), Measurements, Findings, and Conclusions. The 
findings should be clearly listed because it is the list o f findings that will form the main basis for the editorial 
decision. Each finding will be evaluated in terms of its im portance if tru e  and the confidence th a t can 
be placed on it given the evidence. In the case of other types of paper, there are no formal requirements 
for the structure of abstracts but it must be clear from the abstract what conclusions are being drawn because 
evaluation of these will be central to the refereeing process. Abstracts should normally be no more than 250 
words.
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references should be indicated in the typescript by giving the author’s name, with the year o f publication 
in parentheses, e.g. Smith (1984); if there are three authors Smith, Green & Jones (1984) on the first citation 
and Smith et al. (1984) subsequently; or if there are more than three authors Smith et al. (1984) throughout. 
If several papers from the same authors and from the same year are cited, (a), (b), (c), etc. should be put 
after the year of publication. References should be listed at the end of the paper in alphabetical order. 
Examples are:
A b r a m s ,  D. B. & W i l s o n ,  G. T. (1979) Effects of alcohol on social anxiety in women: cognitive versus 
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Guilford Press).
When following the Vancouver system references should be numbered consecutively in the order in which 
they are first mentioned in the text. Identify references in text, tables, and legends by arabic numerals 
(in parentheses). References cited only in tables or in legends to figures should be numbered in accordance 
with a sequence established by the first mention in the text of the particular table or illustration.
The references should be listed in numerical order at the end of the paper. Examples are:
1. C o t t o n ,  N . (1987) The familial incidence of alcoholism, Journal o f  Studies on Alcohol, 40, 89-116.
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Genetics o f Neuropsychiatric Diseases, pp. 2 1 -28  (London, Macmillan).
Whatever referencing system is adopted, titles o f journals should not be abbreviated. All authors should be 
included. The reference list should not be needlessly profligate and should only include items that are 
retrievable through standard bibliographic sources. Where foreign language papers or books are cited, the 
title in English needs to be included in brackets after the foreign language version.
Illustrations
These should not be inserted in the text but each provided separately and numbered on the back with Figure 
numbers, title of paper and name of author. Illustrations should be prepared about twice their final size. 
Three copies of all figures must be submitted. All photographs, graphs and diagrams should be referred to 
as Figures and should be numbered consecutively in the text in Arabic numerals (e.g. Fig 3). The 
approximate position of each illustration should be indicated in the text. A list of captions for the figures 
should be submitted on a separate sheet and should make interpretation possible without reference to the 
text. Captions should include keys to symbols.
Tables
These should be typed on separate sheets and their approximate position in the text should be indicated. 
Units should appear in parentheses in the column heading but not in the body of the table. Words or 
numerals should be repeated on successive lines ‘ditto’ or ‘do’ should not be used. Tables should not be 
ruled.
Proofs
Proofs are supplied for checking and making essential corrections, not for general revision or alteration. 
Proofs should be corrected and returned to the publisher within 3 days of receipt.
Offprints
Fifty offprints of each paper are supplied free. Additional copies may be purchased and should be ordered 
when the proofs are returned. Offprints, together with a complete copy of the relevant journal issue, are sent 
about three weeks after publication.
Refereeing
Papers will normally be sent by the Regional Editor for review to an Assistant Editor who will solicit 
referees’ reports and make a recommendation to the Regional Editor. The regional editor will make a 
decision on the paper and communicate this with the authors. The Regional Editor or the Assistant Editor 
may return a paper unrefereed if in their judgement it is not suitable for the journal because of serious 
methodological limitations, the topic addressed or problems with reporting.
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REVISED INVENTORY OF DRINKING SITUATIONS
Listed below are a number of situations or events that can cause difficulties for people who have had 
an alcohol problem.
Read each item carefully, and answer in terms of your own experience over the past 3 months.
If you “NEVER” felt like drinking in that situation, circle “1”
If you “RARELY” felt like drinking in that situation, circle “2”
If you “FREQUENTLY” felt like drinking in that situation, circle “3”
If you “ALMOST ALWAYS” felt like drinking in that situation, circle “4”
1 FELT LIKE DRINKING
Never Rarely Frequently Almc
Aiwa
1. When I felt that I had let myself down 1 2 3 4
2. When I had trouble sleeping 1 2 3 4
3. When I felt confident and relaxed 1 2 3 4
4. When I convinced myself that I was a
new person and could take a few drinks 1 2 3 4
5 When I remembered how good it tasted 1 2 3 4
6. When I had an argument with a friend 1 2 3 4
7. When I was out with friends and they
stopped at a pub for a drink 1 2 3 4
8. When I wanted to heighten my sexual
enjoyment 1 2 nJ 4
9. When other people didn’t seem to like
me 1 2 3 4
10. When there were fights at home 1 2 3 4
11. When I was relaxed with a good friend
and wanted to have a good time 1 2 3 4
12. When I was afraid that things weren’t
going to work out 1 2 3 4
13. When I felt drowsy and wanted to stay
alert 1 2 3 4
14. When everything was going well 1 2 3 4
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I FELT LIKE DRINKING
15. When I wondered about my 
self-control over alcohol and felt like 
having a drink to try it out
16. When I passed by an off-licence
17. When I felt uneasy in the presence of 
someone
18. When I was at a party and other people 
were drinking
19. When I wanted to feel closer to 
someone I liked
20. When other people interfered with my 
plan
21. When there were problems with people 
at work
22. When I was enjoying myself at a party 
and wanted to feel even better
23. When I was angry at the way things had 
turned out
24. When I felt nauseous
25. When I felt satisfied with something I 
had done
26. When I started to think that just one 
drink could cause no harm
27. When I unexpectedly found a bottle of 
my favourite booze
28. When someone criticised me
29. When I was in a restaurant and the 
people with me ordered drinks
30. When I was out with friends “on the 
town” and wanted to increase my 
enjoyment
Never Rarely Frequently Almost
Always
1 2  3 4
1 2  3 4
1 2  3 4
1 2  3 4
1 2  3 4
1 2  3 4
1 2  3 4
1 2  3 4
1 2  3 4
1 2  3 4
1 2  3 4
1 2  3 4
1 2  3 4
1 2  3 4
1 2  3 4
1 2  3 4
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I FELT LIKE DRINKING
Never Rarely Frequently
31. When pressure built up at work because 
of the demands of my supervisor
32. When other people treated me unfairly
3 3. When I felt confused about what I 
should do
34. When my stomach felt like it was tied 
in knots
35. When something good happened and 
I felt like celebrating
36. When I wanted to prove to myself that I 
could take a few drinks without 
becoming drunk
37. When I suddenly had an urge to drink
38. When other people around me made 
me tense
39. When I met a friend and he/she 
suggested that we have a drink together
40. When I wanted to celebrate with a 
friend
41. When I felt under a lot of pressure from 
family members at home
42. When I was not getting along well with 
others at work 1
Almost
Always
4
4
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CRAVING INDEX
Please answer the following questions using the rating scale provided:
1. How much have you been missing alcohol?
N o t a l a ll  Q u ite  a  lo t
1----------------------- 2------------------------3------------------------ 4------------------------ 5
2. How difficult has it been to do without alcohol?
N o t a l a ll  Q u ite  a  lo t
1----------------------- 2------------------------3------------------------ X------------------------ 5
3. How much have you been aware of not drinking?
N o t a l a ll Q u ite  a  lo t
1----------------------- 2------------------------3------------------------ X------------------------ 5
4. How pre-occupied have you been thinking of alcohol?
N o t a l a ll  Q u ite  a  lo t
1------------------------2------------------------3------------------------4------------------------ 5
5. How much have you craved alcohol?
N o t a l a ll  Q u ite  a  lo t
1------------------------2------------------------3------------------------ X------------------------ 5
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CONFIDENTIAL
ANTABUSE QUESTIONNAIRE
The questions on this form ask what you think about Antabuse treatment and the care you receive. 
Please answer every question on both pages of the form. Your answers will be kept entirely 
confidential so do not write your name on the form. Please be sure to place this form in the box 
provided before you leave today.
1. Where did you first hear about Antabuse treatment?
Friend------------GP------------APTU staff------------APTU patients------------other
2. When did you begin Antabuse treatment?
3. Have you previously received Antabuse treatment?
yes/no
4. Did you feel that you were given enough information about Antabuse before starting treatment?
yes/no
5. Is your Antabuse treatment being supervised?
yes/no
6. If your answer to the above is yes, please state who is providing supervision;
spouse/partner friend GP APTU---- pharmacist— -other
7. Are your satisfied with the number of follow-up appointments you are being offered?
too many about right too few
8. What has been particularly helpful about the way Antabuse treatment has been given?
63
9. What has been particularly unhelpful about Antabuse treatment?
10. Have you experienced any unpleasant side-effects on Antabuse?
11. Are you receiving any other form of therapy/treatment for your alcohol problem at present?
12. What other forms of therapy/treatment do you think we should offer with Antabuse? 
Please list from 1 to 6 according to preference (l=most preferred, 6=least.)
individual counselling and support 
relaxation training
training in coping skills and dealing with high-risk situations 
support group
education about the harmful effects of alcohol 
lifestyle changes
13. How has Antabuse helped you to remain abstinent?
14. Any other comments?
THANK YOU FOR COMPLETING THIS QUESTIONNAIRE
GLASGOW
UNIVERSITY 
I LH5RABY
